Abstract: A use of D-arabitol in lipid-lowering and hepatoprotection is provided. Blood or liver lipid abnormalities refer to abnormalities in a quantity and a quality of lipids in the blood or liver, and usually refer to the elevation of cholesterol and/or triglycerides (TGs). Blood and liver lipid abnormalities can lead to atherosclerosis, increase the morbidity and mortality rates of cardio-cerebrovascular diseases, and cause the liver damage. D-arabitol has an excellent lipid-lowering and hepatoprotective effect, and has a prospect of being developed into a drug or health care product or food for lipid-lowering and hepatoprotection.

Abstract: The present invention provides a generic synchronized motion control system for multiple dynamic systems. Free choices of synchronization strategies are allowed with no implementation modification. Furthermore, synchronization selections are converted into a numerically searchable parameter space that enables systematic development, automated process, and performance optimization. In addition, the present invention enables a uniform computer program of control synchronization algorithm due to its innovation of separating synchronization strategy from control implementation.

Abstract: The present invention provides a generic synchronized motion control system for multiple dynamic systems. Free choices of synchronization strategies are allowed with no implementation modification. Furthermore, synchronization selections are converted into a numerically searchable parameter space that enables systematic development, automated process, and performance optimization. In addition, the present invention enables a uniform computer program of control synchronization algorithm due to its innovation of separating synchronization strategy from control implementation.